Regulation of matrix metalloproteinase-9 (MMP-9), tissue inhibitor of MMP, and progesterone secretion in luteinized granulosa cells from normally ovulating women with polycystic ovary disease
article
OA: closed
CC0
⤵ 3 in-corpus citations
AI-generated summary
This study investigated how polycystic ovary disease affects MMP-9, its inhibitor, and progesterone secretion in luteinized granulosa cells from normally ovulating women.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
ObjectiveTo investigate the regulation of MMP-9, TIMP-1, and progesterone via three signal transduction pathways in luteinized granulosa cells from normal ovulatory and PCOD women.DesignIn vitro study.SettingLaboratory for Research in Reproductive Sciences, Department of Obstetrics and Gynecology, Ha'Emek Hospital, Afula, Israel.Patient(s)Ten normal ovulatory and 10 women with polycystic ovary disease (PCOD) treated in an assisted reproduction program.Intervention(s)Cultured cells were exposed to phorbol 12-myristate 13-acetate (TPA), acting via protein kinase C (PKC), to epidermal growth factor (EGF), acting via protein tyrosine kinase (PTK), and to forskolin, acting via protein kinase A (PKA).Main outcome measure(s)Secretion of MMP-9, TIMP-1, and progesterone.Result(s)Phorbol 12-myristate 13-acetate elicited an increase in MMP-9 and TIMP-1 secretion in both groups and apparently did not affect progesterone secretion. Epidermal growth factor did not change significantly neither MMP-9 nor TIMP-1 secretion but dose dependently decreased MMP-9-TIMP-1 ratio and increased progesterone secretion in the PCOD group. Forskolin inhibited MMP-9 activity and increased TIMP-1 and progesterone secretion in both groups. Progesterone production was inversely related to the ratio of MMP-9-TIMP-1 regardless of cell origin.Conclusion(s)In this preliminary study, similar and divergent patterns have emerged in the regulation of MMP-9 and TIMP-1 in human luteinized granulosa cells. Repressing MMP-9-TIMP-1 ratio may have an important modulatory effect on progesterone secretion.
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (1)
Cited by (3)
- MMPS and TIMPS in ovarian physiology and pathophysiology 2004
- Matrix Metalloproteinases, Tissue Inhibitors of Metalloproteinases, and Their Ratios in Women with Polycystic Ovary Syndrome and Healthy Controls 2025
- Difference in expression of matrix metalloproteinase-2 and matrix metalloproteinase-9 in patients with persistent ovarian cysts 2005
References (34)
- Suppression of matrix metalloproteinase production by hCG in cultures of human luteinized granulosa cells as a model for gonadotrophin-induced luteal rescue via openalex
- doi:10.1007/bf00118181 via openalex
- doi:10.1093/oxfordjournals.humrep.a136243 via openalex
- doi:10.1016/s0002-9440(10)64815-8 via openalex
- doi:10.1016/0303-7207(87)90038-4 via openalex
- doi:10.1507/endocrj.45.175 via openalex
- doi:10.1093/molehr/7.4.325 via openalex
- doi:10.3109/09513590009167657 via openalex
- doi:10.1159/000054201 via openalex
- doi:10.1095/biolreprod62.5.1121 via openalex
- doi:10.1093/humrep/16.12.2606 via openalex
- doi:10.1097/00001703-199404000-00008 via openalex
- W6655140644 via openalex
- W6677507540 via openalex
- doi:10.1210/jcem-50-1-113 via openalex
- doi:10.1016/s0015-0282(97)00356-7 via openalex
- doi:10.1016/s0015-0282(16)57793-0 via openalex
- doi:10.1006/bbrc.1996.1688 via openalex
- doi:10.1093/humupd/4.3.296 via openalex
- doi:10.1210/endo.140.11.7096 via openalex
- doi:10.1124/mol.58.1.145 via openalex
- doi:10.1006/excr.1998.4336 via openalex
- doi:10.1210/jcem.83.7.4950 via openalex
- doi:10.1007/978-1-4899-0952-7_8 via openalex
- doi:10.1210/jcem.79.1.8027214 via openalex
- doi:10.1093/molehr/2.1.26 via openalex
- doi:10.1093/humrep/10.6.1373 via openalex
- doi:10.1002/1098-2744(200009)29:1<8::aid-mc2>3.0.co;2-0 via openalex
- doi:10.1530/jrf.0.0980583 via openalex
- doi:10.1016/s0015-0282(98)00252-0 via openalex
- doi:10.1016/s0950-351x(96)80099-1 via openalex
- doi:10.1210/jcem.82.6.3997 via openalex
- doi:10.1093/molehr/3.1.27 via openalex
- doi:10.1677/joe.0.1610393 via openalex
Cited by (3)
- Matrix Metalloproteinases, Tissue Inhibitors of Metalloproteinases, and Their Ratios in Women with Polycystic Ovary Syndrome and Healthy Controls 2025
- Difference in expression of matrix metalloproteinase-2 and matrix metalloproteinase-9 in patients with persistent ovarian cysts 2005
- MMPS and TIMPS in ovarian physiology and pathophysiology 2004
Source provenance
- openalex
- last seen: 2026-05-11T05:49:40.447239+00:00
License: CC0
· commercial use OK